生物技术和製药服务外包市场规模、份额、成长分析、按服务、按最终用途、按地区 - 行业预测，2025-2032 年

2023年全球生物技术和製药服务外包市场规模为452亿美元，预测期内（2025-2032年）复合年增长率为5.7%，从2024年的477.8亿美元增至2032年。 744.4亿美元。

生物技术和製药服务外包市场已成为全球医疗保健生态系统不可或缺的一部分，推动了更快的药物开发和增强的研究能力。在这个领域，製药和生物技术公司可以委託药物发现、开发和製造外包给专业的第三方供应商，使他们能够专注于核心功能，同时提高业务效率。在研发成本上升和对专业知识的需求的推动下，该市场正在经历显着增长。外包的主要领域包括研发、临床试验和製造，其中CRO（委外研发机构）和CMO（合约药品製造业务）发挥重要作用。外包不仅可以降低财务风险、加速进度，还可以让您灵活应对市场需求。 COVID-19 大流行凸显了外包在加速疫苗开发方面的重要性，而人工智慧和个人化医疗的创新继续塑造着这个不断发展的产业外包的未来。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析及影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究

按服务分類的生物技术和製药服务外包市场规模

• 市场概况
• 咨询
• 监管业务
• 产品设计与开发
• 审核与评估
• 产品维护
• 培训和教育
• 其他的

按最终用途分類的生物技术和製药服务外包市场规模

• 市场概况
• 製药公司
• 生技公司

生技与製药服务外包市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• The Quantic Group（US）
• IQVIA（US）
• Lachman Consultant Services, Inc.（US）
• GMP Pharmaceuticals Pty Ltd.（Australia）
• Concept Heidelberg GmbH（Germany）
• Charles River Laboratories（US）
• ICON plc（Ireland）
• Samsung Biologics（South Korea）
• Lonza（Switzerland）
• Syneos Health（US）

结论和建议

Global Biotechnology & Pharmaceutical Services Outsourcing Market size was valued at USD 45.2 billion in 2023 and is poised to grow from USD 47.78 billion in 2024 to USD 74.44 billion by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The biotechnology and pharmaceutical services outsourcing market has become integral to the global healthcare ecosystem, driving faster drug development and enhanced research capabilities. This sector enables pharmaceutical and biotech firms to delegate drug discovery, development, and manufacturing to specialized third-party providers, allowing them to concentrate on their core functions while improving operational efficiency. Influenced by rising R&D costs and the demand for specialized expertise, this market has experienced significant growth. Key areas of outsourcing include research and development, clinical trials, and manufacturing, with contract research organizations (CROs) and contract manufacturing organizations (CMOs) playing crucial roles. Outsourcing not only mitigates financial risks and accelerates timelines but also provides flexibility in responding to market demands. The COVID-19 pandemic highlighted its importance in expediting vaccine development, while innovations in AI and personalized medicine continue to shape the future of outsourcing in this evolving industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biotechnology & Pharmaceutical Services Outsourcing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biotechnology & Pharmaceutical Services Outsourcing Market Segmental Analysis

Global Biotechnology & Pharmaceutical Services Outsourcing Market is segmented by Service, End-use, and region. Based on Service, the market is segmented into Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education, and Others. Based on End-use, the market is segmented into Pharmaceutical Companies, and Biotech Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biotechnology & Pharmaceutical Services Outsourcing Market

The Global Biotechnology and Pharmaceutical Services Outsourcing market is significantly driven by the need for cost efficiency and flexibility among pharmaceutical and biotechnology companies. By outsourcing various phases of drug development and manufacturing to specialized contract research organizations (CROs) and contract manufacturing organizations (CMOs), these companies can achieve substantial cost savings. This approach enables them to leverage expert knowledge and advanced infrastructure without the burdensome financial commitment of building and maintaining their own facilities. Furthermore, the outsourcing model offers the adaptability to adjust operational capacity according to project demands, facilitating a more responsive and efficient development process.

Restraints in the Global Biotechnology & Pharmaceutical Services Outsourcing Market

The Global Biotechnology and Pharmaceutical Services Outsourcing market faces several significant restraints, particularly concerning quality control and intellectual property issues. When outsourcing vital components of drug development and manufacturing, companies often grapple with the challenge of upholding stringent quality control standards while ensuring the protection of their proprietary information. There is a heightened need for careful management to guarantee that outsourced services comply with regulatory requirements and effectively safeguard sensitive data. Failure to address these concerns could jeopardize product quality and lead to potential risks regarding intellectual property theft, ultimately impacting a company's reputation and competitiveness in the market.

Market Trends of the Global Biotechnology & Pharmaceutical Services Outsourcing Market

The Global Biotechnology & Pharmaceutical Services Outsourcing market is experiencing a notable trend characterized by the rising demand for specialized services. As biotechnology and pharmaceutical companies pivot towards outsourcing, they are increasingly partnering with contract research organizations (CROs) and contract manufacturing organizations (CMOs) that offer targeted expertise in critical areas such as clinical trials, drug development, regulatory compliance, and manufacturing processes. This shift is largely motivated by the desire to leverage specialized knowledge without the financial and operational burden of maintaining extensive in-house resources, thereby enhancing efficiency and driving innovation throughout the drug discovery and commercialization landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Biotechnology & Pharmaceutical Services Outsourcing Market Size by Service & CAGR (2025-2032)

• Market Overview
• Consulting
• Regulatory Affairs
• Product Design & Development
• Auditing and Assessment
• Product Maintenance
• Training & Education
• Others

Global Biotechnology & Pharmaceutical Services Outsourcing Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Biotech Companies

Global Biotechnology & Pharmaceutical Services Outsourcing Market Size & CAGR (2025-2032)

• North America, (Service, End-use)
  • US
  • Canada
• Europe, (Service, End-use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Service, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Service, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Service, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• The Quantic Group (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lachman Consultant Services, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GMP Pharmaceuticals Pty Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Concept Heidelberg GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation